Predictors of Appropriate ICD Therapy in Patients with Arrhythmogenic Right Ventricular Cardiomyopathy: Long Term Experience of a Tertiary Care Center

PLoS ONE

Volumn 7, Issue 9, 2012, Pages

  Schuler, Pia K ^a,b   Haegeli, Laurent M ^a   Saguner, Ardan M ^a   Wolber, Thomas ^a,c   Tanner, Felix C ^a,c   Jenni, Rolf ^a,c   Corti, Natascia ^a   Lüscher, Thomas F ^a,c   Brunckhorst, Corinna ^a   Duru, Firat ^a,c  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^c UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; ARTICLE; CLINICAL ARTICLE; FAINTNESS; FEMALE; FOLLOW UP; HEART ELECTROPHYSIOLOGY; HEART FAILURE; HEART LEFT VENTRICLE; HEART RIGHT VENTRICLE DYSPLASIA; HEART VENTRICLE ARRHYTHMIA; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; MALE; MORTALITY; PREDICTIVE VALUE; PROGNOSIS; RETROSPECTIVE STUDY; SECONDARY PREVENTION; TERTIARY HEALTH CARE; TRANSTHORACIC ECHOCARDIOGRAPHY;

ADULT; ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA; DEFIBRILLATORS, IMPLANTABLE; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TERTIARY CARE CENTERS; TREATMENT OUTCOME;

SYNCOPE;

EID: 84866887359     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0039584     Document Type: Article

References (35)

1. Maron BJ, Shirani J, Poliac LC, Mathenge R, Roberts WC, et al. (1996) Sudden death in young competitive athletes. Clinical, demographic, and pathological profiles. JAMA 276: 199-204.
2. Shen WK, Edwards WD, Hammill SC, Bailey KR, Ballard DJ, et al. (1995) Sudden unexpected nontraumatic death in 54 young adults: a 30-year population-based study. Am J Cardiol 76: 148-152.
3. Corrado D, Basso C, Schiavon M, Thiene G, (1998) Screening for hypertrophic cardiomyopathy in young athletes. N Engl J Med 339: 364-369.
4. Tabib A, Miras A, Taniere P, Loire R, (1999) Undetected cardiac lesions cause unexpected sudden cardiac death during occasional sport activity. A report of 80 cases. Eur Heart J 20: 900-903.
5. Thiene G, Nava A, Corrado D, Rossi L, Pennelli N, (1988) Right ventricular cardiomyopathy and sudden death in young people. N Engl J Med 318: 129-133.
6. Corrado D, Thiene G, Nava A, Rossi L, Pennelli N, (1990) Sudden death in young competitive athletes: clinicopathologic correlations in 22 cases. Am J Med 89: 588-596.
7. Marcus FI, Fontaine GH, Guiraudon G, Frank R, Laurenceau JL, et al. (1982) Right ventricular dysplasia: a report of 24 adult cases. Circulation 65: 384-398.
8. Corrado D, Basso C, Thiene G, (2001) Sudden cardiac death in young people with apparently normal heart. Cardiovasc Res 50: 399-408.
9. Pinamonti B, Dragos AM, Pyxaras SA, Merlo M, Pivetta A, et al. (2011) Prognostic predictors in arrhythmogenic right ventricular cardiomyopathy: results from a 10-year registry. Eur Heart J 32: 1105-1113.
10. Marcus FI, Zareba W, Calkins H, Towbin JA, Basso C, et al. (2009) Arrhythmogenic right ventricular cardiomyopathy/dysplasia clinical presentation and diagnostic evaluation: results from the North American Multidisciplinary Study. Heart Rhythm 6: 984-992.
11. Kullo IJ, Edwards WD, Seward JB, (1995) Right ventricular dysplasia: the Mayo Clinic experience. Mayo Clin Proc 70: 541-548.
12. Pinamonti B, Di Lenarda A, Sinagra G, Silvestri F, Bussani R, et al. (1995) Long-term evolution of right ventricular dysplasia-cardiomyopathy. The Heart Muscle Disease Study Group. Am Heart J 129: 412-415.
13. Zipes DP, Camm AJ, Borggrefe M, Buxton AE, Chaitman B, et al. (2006) ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (writing committee to develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation 114: e385-484.
14. Hodgkinson KA, Parfrey PS, Bassett AS, Kupprion C, Drenckhahn J, et al. (2005) The impact of implantable cardioverter-defibrillator therapy on survival in autosomal-dominant arrhythmogenic right ventricular cardiomyopathy (ARVD5). J Am Coll Cardiol 45: 400-408.
15. Berul CI, Van Hare GF, Kertesz NJ, Dubin AM, Cecchin F, et al. (2008) Results of a multicenter retrospective implantable cardioverter-defibrillator registry of pediatric and congenital heart disease patients. J Am Coll Cardiol 51: 1685-1691.
16. Link MS, Wang PJ, Haugh CJ, Homoud MK, Foote CB, et al. (1997) Arrhythmogenic right ventricular dysplasia: clinical results with implantable cardioverter defibrillators. J Interv Card Electrophysiol 1: 41-48.
17. Tavernier R, Gevaert S, De Sutter J, De Clercq A, Rottiers H, et al. (2001) Long term results of cardioverter-defibrillator implantation in patients with right ventricular dysplasia and malignant ventricular tachyarrhythmias. Heart 85: 53-56.
18. Tandri H, Macedo R, Calkins H, Marcus F, Cannom D, et al. (2008) Role of magnetic resonance imaging in arrhythmogenic right ventricular dysplasia: insights from the North American arrhythmogenic right ventricular dysplasia (ARVD/C) study. Am Heart J 155: 147-153.
19. Piccini JP, Dalal D, Roguin A, Bomma C, Cheng A, et al. (2005) Predictors of appropriate implantable defibrillator therapies in patients with arrhythmogenic right ventricular dysplasia. Heart Rhythm 2: 1188-1194.
20. Roguin A, Bomma CS, Nasir K, Tandri H, Tichnell C, et al. (2004) Implantable cardioverter-defibrillators in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy. J Am Coll Cardiol 43: 1843-1852.
21. McKenna WJ, Thiene G, Nava A, Fontaliran F, Blomstrom-Lundqvist C, et al. (1994) Diagnosis of arrhythmogenic right ventricular dysplasia/cardiomyopathy. Task Force of the Working Group Myocardial and Pericardial Disease of the European Society of Cardiology and of the Scientific Council on Cardiomyopathies of the International Society and Federation of Cardiology. Br Heart J 71: 215-218.
22. Marcus FI, McKenna WJ, Sherrill D, Basso C, Bauce B, et al. (2010) Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the task force criteria. Circulation 121: 1533-1541.
23. Marcus F, Basso C, Gear K, Sorrell VL, (2010) Pitfalls in the diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia. Am J Cardiol 105: 1036-1039.
24. Sahn DJ, DeMaria A, Kisslo J, Weyman A, (1978) Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 58: 1072-1083.
25. Schiller NB, Shah PM, Crawford M, DeMaria A, Devereux R, et al. (1989) Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 2: 358-367.
26. Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, et al. (1986) Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 57: 450-458.
27. Jenni R, Vieli A, Hess O, Anliker M, Krayenbuehl HP, (1981) Estimation of left ventricular volume from apical orthogonal 2-D echocardiograms. Eur Heart J 2: 217-225.
28. Nicolosi GL, (2008) Trattato di Ecocardiografia clinica: Edizioni Piccin.
29. Corrado D, Leoni L, Link MS, Della Bella P, Gaita F, et al. (2003) Implantable cardioverter-defibrillator therapy for prevention of sudden death in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia. Circulation 108: 3084-3091.
30. Wichter T, Paul M, Wollmann C, Acil T, Gerdes P, et al. (2004) Implantable cardioverter/defibrillator therapy in arrhythmogenic right ventricular cardiomyopathy: single-center experience of long-term follow-up and complications in 60 patients. Circulation 109: 1503-1508.
31. Marcus GM, Glidden DV, Polonsky B, Zareba W, Smith LM, et al. (2009) Efficacy of antiarrhythmic drugs in arrhythmogenic right ventricular cardiomyopathy: a report from the North American ARVC Registry. J Am Coll Cardiol 54: 609-615.
32. Lemola K, Brunckhorst C, Helfenstein U, Oechslin E, Jenni R, et al. (2005) Predictors of adverse outcome in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy: long term experience of a tertiary care centre. Heart 91: 1167-1172.
33. Komura M, Suzuki J, Adachi S, Takahashi A, Otomo K, et al. (2010) Clinical course of arrhythmogenic right ventricular cardiomyopathy in the era of implantable cardioverter-defibrillators and radiofrequency catheter ablation. Int Heart J 51: 34-40.
34. Corrado D, Calkins H, Link MS, Leoni L, Favale S, et al. (2010) Prophylactic implantable defibrillator in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia and no prior ventricular fibrillation or sustained ventricular tachycardia. Circulation 122: 1144-1152.
35. Bhonsale A, James CA, Tichnell C, Murray B, Gagarin D, et al. (2011) Incidence and predictors of implantable cardioverter-defibrillator therapy in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy undergoing implantable cardioverter-defibrillator implantation for primary prevention. J Am Coll Cardiol 58: 1485-1496.